NATCO Pharma Ltd Q4 FY20 consolidated PAT drops to Rs. 94.1 crore

NATCO PHARMA LTD. has reported financial results for the period ended March 31, 2020.

Financial Results (Q4 FY19-20) - QoQ Comparison

The company has reported net sales of Rs.477.2 crores during the period ended March 31, 2020 as compared to Rs.513 crores during the period ended December 31, 2019.

The company has posted net profit of Rs.94.1 crores for the period ended March 31, 2020 as against Rs.104.5 crores for the period ended December 31, 2019.

The company has reported EPS of Rs.5.16 for the period ended March 31, 2020 as compared to Rs.5.73 for the period ended December 31, 2019.

Financials	Q4 FY19-20	Q3 FY19-20	% Change
Total Income	₹ 477.2 crs	₹ 513 crs	-6.98%
Net Profit	₹ 94.1 crs	₹ 104.5 crs	-9.95%
EPS	₹ 5.16	₹ 5.73	-9.95%

Financial Results (Q4 FY19-20) - YoY Comparison

The company has reported net sales of Rs.477.2 crores during the period ended March 31, 2020 as compared to Rs.486.7 crores during the period ended March 31, 2019.

The company has posted net profit of Rs.94.1 crores for the period ended March 31, 2020 as against Rs.120.8 crores for the period ended March 31, 2019.

The company has reported EPS of Rs.5.16 for the period ended March 31, 2020 as compared to Rs.6.58 for the period ended March 31, 2019.

Financials	Q4 FY19-20	Q4 FY18-19	% Change
Total Income	₹ 477.2 crs	₹ 486.7 crs	-1.95%
Net Profit	₹ 94.1 crs	₹ 120.8 crs	-22.1%
EPS	₹ 5.16	₹ 6.58	-21.58%

Financial Results (Year ended FY 2019-20) - YoY Comparison

The company has reported net sales of Rs.2022.4 crores during the 12 months period ended March 31, 2020 as compared to Rs.2224.7 crores during the 12 months period ended March 31, 2019.

The company has posted net profit of Rs.460.8 crores for the 12 months period ended March 31, 2020 as against Rs.644.4 crores for the 12 months period ended March 31, 2019.

The company has reported EPS of Rs.25.26 for the 12 months period ended March 31, 2020 as compared to Rs.34.87 for the 12 months period ended March 31, 2019.

Financials	FY2019-20	FY2018-19	% Change
Total Income	₹ 2022.4 crs	₹ 2224.7 crs	-9.09%
Net Profit	₹ 460.8 crs	₹ 644.4 crs	-28.49%
EPS	₹ 25.26	₹34.87	-27.56%

Shares of NATCO PHARMA LTD. was last trading in BSE at Rs.639.2 as compared to the previous close of Rs. 604.8. The total number of shares traded during the day was 24225 in over 2043 trades.

The stock hit an intraday high of Rs. 643.55 and intraday low of 612. The net turnover during the day was Rs. 15296932.

Source : Equity Bulls

Keywords